Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
ACS Medicinal Chemistry Letters
|
October 16, 2020
Peptoid NPhe<sup>4</sup> in AGRP-Based c[Pro<sup>1</sup>-Arg<sup>2</sup>-Phe<sup>3</sup>-Phe<sup>4</sup>-Xxx<sup>5</sup>-Ala<sup>6</sup>-Phe<sup>7</sup>-DPro<sup>8</sup>] Scaffolds Maintain Mouse MC4R Antagonist Potency
Mark D Ericson, Katie T Freeman, Carrie Haskell-Luevano
Bioorganic & Medicinal Chemistry Letters
|
October 5, 2015
A fragment of the Escherichia coli ClpB heat-shock protein is a micromolar melanocortin 1 receptor agonist
Mark D Ericson, Sathya M Schnell, Katie T Freeman, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy
Marshall D Winget, Mark D Ericson, Katie T Freeman, et al.
Journal of Medicinal Chemistry
|
January 4, 2017
A Macrocyclic Agouti-Related Protein/[Nle<sup>4</sup>,DPhe<sup>7</sup>]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands
Mark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
Journal of Medicinal Chemistry
|
July 24, 2018
Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists
Katlyn A Fleming, Katie T Freeman, Mark D Ericson, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist
Mark D Ericson, Romessa Shaikh, Courtney M Larson, et al.
ACS Pharmacology & Translational Science
|
January 16, 2025
Recommended Opioid Receptor Tool Compounds: Comparative <i>In Vitro</i> for Receptor Selectivity Profiles and <i>In Vivo</i> for Pharmacological Antinociceptive Profiles
Linh T Tran, Katie T Freeman, Mary M Lunzer, et al.
Journal of Medicinal Chemistry
|
August 17, 2017
Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor
Mark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
ACS Chemical Neuroscience
|
June 21, 2018
Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles
Mark D Ericson, Zoe M Koerperich, Katie T Freeman, et al.
ACS Omega
|
August 15, 2022
Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist Tetrapeptide
Mark D Ericson, Courtney M Larson, Katie T Freeman, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
ACS Medicinal Chemistry Letters
|
October 16, 2020
Peptoid NPhe<sup>4</sup> in AGRP-Based c[Pro<sup>1</sup>-Arg<sup>2</sup>-Phe<sup>3</sup>-Phe<sup>4</sup>-Xxx<sup>5</sup>-Ala<sup>6</sup>-Phe<sup>7</sup>-DPro<sup>8</sup>] Scaffolds Maintain Mouse MC4R Antagonist Potency
Mark D Ericson, Katie T Freeman, Carrie Haskell-Luevano
Bioorganic & Medicinal Chemistry Letters
|
October 5, 2015
A fragment of the Escherichia coli ClpB heat-shock protein is a micromolar melanocortin 1 receptor agonist
Mark D Ericson, Sathya M Schnell, Katie T Freeman, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2020
Single Nucleotide Polymorphisms in the Melanocortin His-Phe-Arg-Trp Sequences Decrease Tetrapeptide Potency and Efficacy
Marshall D Winget, Mark D Ericson, Katie T Freeman, et al.
Journal of Medicinal Chemistry
|
January 4, 2017
A Macrocyclic Agouti-Related Protein/[Nle<sup>4</sup>,DPhe<sup>7</sup>]α-Melanocyte Stimulating Hormone Chimeric Scaffold Produces Subnanomolar Melanocortin Receptor Ligands
Mark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
Journal of Medicinal Chemistry
|
July 24, 2018
Synergistic Multiresidue Substitutions of a Macrocyclic c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-dPro] Agouti-Related Protein (AGRP) Scaffold Yield Potent and >600-Fold MC4R versus MC3R Selective Melanocortin Receptor Antagonists
Katlyn A Fleming, Katie T Freeman, Mark D Ericson, et al.
ACS Medicinal Chemistry Letters
|
January 25, 2021
Multiresidue Tetrapeptide Substitutions Yield a 140-fold Selective Melanocortin-3 over Melanocortin-4 Receptor Agonist
Mark D Ericson, Romessa Shaikh, Courtney M Larson, et al.
ACS Pharmacology & Translational Science
|
January 16, 2025
Recommended Opioid Receptor Tool Compounds: Comparative <i>In Vitro</i> for Receptor Selectivity Profiles and <i>In Vivo</i> for Pharmacological Antinociceptive Profiles
Linh T Tran, Katie T Freeman, Mary M Lunzer, et al.
Journal of Medicinal Chemistry
|
August 17, 2017
Structure-Activity Relationship Studies on a Macrocyclic Agouti-Related Protein (AGRP) Scaffold Reveal Agouti Signaling Protein (ASP) Residue Substitutions Maintain Melanocortin-4 Receptor Antagonist Potency and Result in Inverse Agonist Pharmacology at the Melanocortin-5 Receptor
Mark D Ericson, Katie T Freeman, Sathya M Schnell, et al.
ACS Chemical Neuroscience
|
June 21, 2018
Arg-Phe-Phe d-Amino Acid Stereochemistry Scan in the Macrocyclic Agouti-Related Protein Antagonist Scaffold c[Pro-Arg-Phe-Phe-Xxx-Ala-Phe-DPro] Results in Unanticipated Melanocortin-1 Receptor Agonist Profiles
Mark D Ericson, Zoe M Koerperich, Katie T Freeman, et al.
ACS Omega
|
August 15, 2022
Incorporation of Indoylated Phenylalanine Yields a Sub-Micromolar Selective Melanocortin-4 Receptor Antagonist Tetrapeptide
Mark D Ericson, Courtney M Larson, Katie T Freeman, et al.
Page
of 4